You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

angiotensin II type 1 receptor blocker

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)

Not yet recruiting
  • Coarctation of Aorta
  • High Blood Pressure
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)

Not yet recruiting
  • Aortic Valve Stenosis
  • +5 more
  • Limoges, France
    Limoges university hospital
Dec 23, 2022

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Cardiovascular Diseases, Hypertension Trial in San Francisco (Losartan, Placebo)

Recruiting
  • Cardiovascular Diseases
  • Hypertension
  • San Francisco, California
    San Francisco Veterans' Affairs Medical Center
Apr 29, 2022

Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

Completed
  • Pulmonary Hypertension
  • Sacubitril / Valsartan Oral Tablet [Entresto]
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol University Hospital
Sep 23, 2021

Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)

Recruiting
  • Heart Failure
  • Sacubitril Valsartan Sodium Hydrate
  • Standard treatment
  • Saga, Japan
    Saga University Hospital
Dec 27, 2021

Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)

Recruiting
  • Idiopathic Membranous Nephropathy
  • 100 mg AP1189
  • Placebo
  • Aarhus, Denmark
    Aarhus Universitetshospital
Sep 21, 2021

Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)

Not yet recruiting
  • Breast Cancer
  • +12 more
  • Opole, Opolskie, Poland
  • +3 more
Jul 15, 2022

Coronavirus Disease(COVID)-19 Acute Respiratory Distress

Recruiting
  • COVID
  • Acute Respiratory Distress Syndrome
  • Angiotensin II
  • Interleukin-1 receptor antagonist
  • London, United Kingdom
    Guy's & St Thomas' Hospital
Aug 3, 2021

Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

Recruiting
  • Diabetes Mellitus
  • Cardiovascular Diseases
  • Renin-angiotensin-aldosterone system inhibitors
  • +2 more
  • Singapore, Singapore
    Singapore General Hospital (SGH)
Apr 28, 2021

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)

Completed
Has Results
  • SARS-CoV-2
  • COVID-19
  • ACE inhibitor, angiotensin receptor blocker
  • Innsbruck, Tyrol, Austria
  • +30 more
Aug 18, 2022

ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and

Completed
  • COVID-19
    • Pozzilli, Italy
      IRCCS Neuromed, Department of Epidemiology and Prevention
    Sep 14, 2020

    Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)

    Completed
    • Cognitively Normal Older Adults
    • +3 more
    • Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
    • +3 more
    • Kansas City, Kansas
    • +3 more
    Feb 12, 2022

    SARS-CoV Infection Trial in La Mesa, San Diego (Losartan)

    Completed
    Has Results
    • SARS-CoV Infection
    • La Mesa, California
    • +2 more
    May 24, 2021

    Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)

    Completed
    • Coronavirus Disease 2019
    • COVID-19
    • Angiotensin Receptor Blockers
    • Placebo
    • Camperdown, New South Wales, Australia
    • +21 more
    Mar 2, 2022

    Chronic Kidney Disease, Proteinuria, Children Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))

    Not yet recruiting
    • Chronic Kidney Disease
    • +2 more
    • Finerenone (Kerendia, BAY94-8862)
    • Multiple Locations, Australia
    • +22 more
    Aug 10, 2022

    Ehlers-Danlos Syndrome, Vascular Type Trial in France (Irbesartan, Placebo)

    Completed
    • Ehlers-Danlos Syndrome, Vascular Type
    • Bordeaux, France
    • +14 more
    Nov 2, 2020

    Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV Trial in Phoenix, Tucson (Angiotensin

    Not yet recruiting
    • Heart Failure NYHA Class II
    • +2 more
    • Angiotensin 1-7
    • Saline solution
    • Phoenix, Arizona
    • +1 more
    Apr 12, 2022

    PTSD Trial in United States (losartan, Placebo)

    Completed
    Has Results
    • Posttraumatic Stress Disorder
    • La Jolla, California
    • +5 more
    Feb 19, 2021

    Hypertension Trial in London (Preoperative ACEi/ARB management)

    Completed
    • Hypertension
    • Preoperative ACEi/ARB management
    • London, Ontario, Canada
      London Health Sciences Centre
    Oct 21, 2021

    Focal Segmental Glomerulosclerosis Trial in Worldwide (sparsentan, Irbesartan)

    Active, not recruiting
    • Focal Segmental Glomerulosclerosis
    • Mesa, Arizona
    • +224 more
    Oct 27, 2022

    Resistant Hypertension Trial in Worldwide (Experimental drug, Placebo)

    Recruiting
    • Resistant Hypertension
    • Experimental drug
    • Placebo
    • Guntersville, Alabama
    • +28 more
    Jan 13, 2023

    Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As

    Recruiting
    • Atrial Fibrillation
    • +2 more
    • As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
    • Burlington, Vermont
      University of Vermont Medical Center
    Feb 28, 2023